TW197380B
(ru)
*
|
1990-03-02 |
1993-01-01 |
Glaxo Group Ltd |
|
SK280967B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
US6055980A
(en)
*
|
1991-05-20 |
2000-05-02 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5785049A
(en)
*
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
ES2302332T3
(es)
*
|
1994-09-21 |
2008-07-01 |
Nektar Therapeutics |
Aparato y metodos para dispersar medicamentos en polvo seco.
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US5645051A
(en)
*
|
1995-04-21 |
1997-07-08 |
Dura Pharmaceuticals, Inc. |
Unit dose dry powder inhaler
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5669973A
(en)
*
|
1995-06-06 |
1997-09-23 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing and retaining materials upon a substrate
|
US5714007A
(en)
*
|
1995-06-06 |
1998-02-03 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
|
US20040237961A1
(en)
*
|
1995-06-08 |
2004-12-02 |
Snow John Medlin |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
DE19523516C1
(de)
*
|
1995-06-30 |
1996-10-31 |
Asta Medica Ag |
Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
|
US5642727A
(en)
*
|
1995-07-25 |
1997-07-01 |
David Sarnoff Research Center, Inc. |
Inhaler apparatus using a tribo-electric charging technique
|
US5875776A
(en)
*
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
NZ332669A
(en)
*
|
1996-04-29 |
1999-02-25 |
Dura Pharma Inc |
A dry power inhalation system which is flow rate independent
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US5871010A
(en)
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
US5794613A
(en)
*
|
1997-01-09 |
1998-08-18 |
Sepracor, Inc. |
Multiple-dose dispenser for dry powder inhalers
|
TW469832U
(en)
*
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
SE9700937D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler I
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US5954047A
(en)
*
|
1997-10-17 |
1999-09-21 |
Systemic Pulmonary Development, Ltd. |
Methods and apparatus for delivering aerosolized medication
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6237591B1
(en)
|
1998-11-02 |
2001-05-29 |
Dura Pharmaceuticals, Inc. |
Turbine dry powder inhaler
|
CN1301185A
(zh)
|
1997-12-02 |
2001-06-27 |
杜兰药品公司 |
干粉吸入器
|
US6192876B1
(en)
|
1997-12-12 |
2001-02-27 |
Astra Aktiebolag |
Inhalation apparatus and method
|
US6352722B1
(en)
|
1997-12-23 |
2002-03-05 |
Quadrant Holdings Cambridge Limited |
Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
|
US6004268A
(en)
*
|
1998-04-21 |
1999-12-21 |
Addington; W. Robert |
Aspiration screening process for assessing post surgery patient's risk for pneumonia
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
US6149774A
(en)
|
1998-06-10 |
2000-11-21 |
Delsys Pharmaceutical Corporation |
AC waveforms biasing for bead manipulating chucks
|
SE512386C2
(sv)
*
|
1998-07-30 |
2000-03-06 |
Microdrug Ag |
Förfarande och anordning för klassificering av elektrostatiskt laddat pulverformigt material
|
UA73924C2
(en)
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
FR2787031B1
(fr)
*
|
1998-12-11 |
2001-03-30 |
Valois Sa |
Dispositif d'inhalation ameliore
|
EP1139746A4
(en)
|
1998-12-22 |
2003-09-17 |
Univ North Carolina |
CONNECTIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY DISEASES AND THE ADMINISTRATION OF MEDICINAL SUBSTANCES
|
US6923979B2
(en)
*
|
1999-04-27 |
2005-08-02 |
Microdose Technologies, Inc. |
Method for depositing particles onto a substrate using an alternating electric field
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
PT1196430E
(pt)
*
|
1999-06-29 |
2012-04-18 |
Mannkind Corp |
Purificação e estabilização de péptidos e proteínas em agentes farmacêuticos
|
US7464706B2
(en)
*
|
1999-07-23 |
2008-12-16 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
US20010029947A1
(en)
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
US6651655B1
(en)
*
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
MXPA02008403A
(es)
|
2000-02-28 |
2004-09-27 |
Vectura Ltd |
Mejoras en o relacionadas con el suministro de farmacos por via oral.
|
US20040115133A1
(en)
*
|
2000-05-10 |
2004-06-17 |
Wermeling Daniel P. |
Intranasal opioid compositions
|
US6948494B1
(en)
*
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
TWI290473B
(en)
|
2000-05-10 |
2007-12-01 |
Alliance Pharma |
Phospholipid-based powders for drug delivery
|
US6610271B2
(en)
*
|
2000-05-10 |
2003-08-26 |
University Of Kentucky Research Foundation |
System and method for intranasal administration of lorazepam
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US20060083691A1
(en)
*
|
2000-05-10 |
2006-04-20 |
Wermeling Daniel P |
Intranasal opioid compositions, delivery devices and methods of using same
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
PE20020066A1
(es)
*
|
2000-06-23 |
2002-02-23 |
Norton Healthcare Ltd |
Deposito de dosis medidas previamente para inhalador de polvo seco accionado por la respiracion
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
UA81743C2
(ru)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНОЕ АНТИТЕЛО ЧЕЛОВЕКА, КОТОРОЕ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТСЯ С ФАКТОРОМ НЕКРОЗА ОПУХОЛЕЙ АЛЬФА (ФНПα), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ ЕГО СОДЕРЖИТ, И СПОСОБ ЛЕЧЕНИЯ РЕВМАТОИДНОГО АРТРИТА
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
WO2002013897A2
(en)
|
2000-08-14 |
2002-02-21 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
AU2001286518A1
(en)
*
|
2000-08-15 |
2002-02-25 |
University Of Kentucky Research Foundation |
Programmable multi-dose intranasal drug delivery device
|
US20040176359A1
(en)
*
|
2001-02-20 |
2004-09-09 |
University Of Kentucky Research Foundation |
Intranasal Benzodiazepine compositions
|
US6766799B2
(en)
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
WO2002092154A1
(en)
|
2001-04-26 |
2002-11-21 |
New England Pharmaceuticals, Inc. |
Metered dose delivery device for liquid and powder agents
|
FI20011317A0
(fi)
*
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Jauheinhalaattori
|
JP3619176B2
(ja)
*
|
2001-09-14 |
2005-02-09 |
オムロンヘルスケア株式会社 |
エアロゾル粒子分別装置及び吸入器
|
WO2003024514A1
(en)
*
|
2001-09-19 |
2003-03-27 |
Advent Pharmaceuticals Pty Ltd |
An inhaler
|
WO2003026559A2
(en)
*
|
2001-09-28 |
2003-04-03 |
Kurve Technology, Inc |
Nasal nebulizer
|
AU2002346369B2
(en)
|
2001-11-14 |
2009-08-27 |
Eusa Pharma (Uk) Ltd |
Anti-IL-6 antibodies, compositions, methods and uses
|
MXPA04005865A
(es)
|
2001-12-19 |
2004-09-13 |
Nektar Therapeutics |
Suministro de aminoglucosidos a los pulmones.
|
ATE421249T1
(de)
|
2002-02-13 |
2009-02-15 |
Immunology Lab Inc |
Zusammensetzungen und verfahren für die behandlung von mikroorganismen-infektionen
|
CA2479751C
(en)
|
2002-03-20 |
2008-06-03 |
Trent Poole |
Inhalation apparatus
|
EP1503754B1
(en)
*
|
2002-04-19 |
2005-11-23 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
WO2003099359A1
(en)
*
|
2002-05-09 |
2003-12-04 |
Kurve Technology, Inc. |
Particle dispersion chamber for nasal nebulizer
|
US6889690B2
(en)
|
2002-05-10 |
2005-05-10 |
Oriel Therapeutics, Inc. |
Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
|
US7118010B2
(en)
*
|
2002-05-10 |
2006-10-10 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for dispensing and /or evaluating dry powders
|
US7677411B2
(en)
|
2002-05-10 |
2010-03-16 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
|
US6985798B2
(en)
*
|
2002-05-10 |
2006-01-10 |
Oriel Therapeutics, Inc. |
Dry powder dose filling systems and related methods
|
WO2004002395A2
(en)
|
2002-06-27 |
2004-01-08 |
Oriel Therapeutics, Inc. |
Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders
|
WO2004002417A2
(en)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Mammalian ch1 deleted mimetibodies, compositions, methods and uses
|
AU2003278565A1
(en)
*
|
2002-10-25 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
AR042452A1
(es)
*
|
2002-12-13 |
2005-06-22 |
Otsuka Pharma Co Ltd |
Dispositivo de inhalacion para la administrcion transpulmonar
|
GB0303870D0
(en)
*
|
2003-02-20 |
2003-03-26 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
JP4805824B2
(ja)
|
2003-08-18 |
2011-11-02 |
パリオン・サイエンシィズ・インコーポレーテッド |
キャップ化ピラジノイルグアニジンナトリウムチャネルブロッカー
|
US20070131230A1
(en)
*
|
2003-09-05 |
2007-06-14 |
Kurve Technology, Inc. |
Nasal adapter for the base of the nose
|
JP5144070B2
(ja)
*
|
2003-09-05 |
2013-02-13 |
カーブ テクノロジー,インコーポレイティド |
鼻腔深部及び副鼻腔に薬剤を点鼻送達するための一体型ネブライザ及び粒子分散チャンバ
|
CN1856296A
(zh)
*
|
2003-09-30 |
2006-11-01 |
阿库斯菲尔公司 |
可注射的、口服、或局部用缓释药物制剂
|
UA89481C2
(ru)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Эритропоэтиновые миметические шарнирно-сердцевинные миметитела человека, композиции, способы и применение
|
US7377277B2
(en)
|
2003-10-27 |
2008-05-27 |
Oriel Therapeutics, Inc. |
Blister packages with frames and associated methods of fabricating dry powder drug containment systems
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
US7451761B2
(en)
|
2003-10-27 |
2008-11-18 |
Oriel Therapeutics, Inc. |
Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
|
WO2005040163A1
(en)
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
KR20060110353A
(ko)
*
|
2004-01-12 |
2006-10-24 |
맨카인드 코포레이션 |
제2형 당뇨병 환자에서 혈청 프로인슐린 농도의 감소 방법
|
GB0400804D0
(en)
|
2004-01-14 |
2004-02-18 |
Innoscience Technology Bv |
Pharmaceutical compositions
|
US7607435B2
(en)
*
|
2004-01-21 |
2009-10-27 |
Battelle Memorial Institute |
Gas or liquid flow sensor
|
US7491194B1
(en)
|
2004-02-03 |
2009-02-17 |
David Oliwa |
Remote control valve for urine collection bag
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
WO2005097175A2
(en)
|
2004-03-31 |
2005-10-20 |
Centocor, Inc. |
Human glp-1 mimetibodies, compositions, methods and uses
|
US20060147520A1
(en)
*
|
2004-07-26 |
2006-07-06 |
Curtis Ruegg |
Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
|
KR101273120B1
(ko)
|
2004-08-20 |
2013-06-13 |
맨카인드 코포레이션 |
다이케토피페라진 합성의 촉매 작용
|
KR101644250B1
(ko)
|
2004-08-23 |
2016-07-29 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
GB0427858D0
(en)
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427856D0
(en)
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
EP1674151B1
(de)
*
|
2004-12-23 |
2008-04-16 |
Kinematica Ag |
Vorrichtung zum Dispergieren eines festen, flüssigen oder gasförmigen Stoffes in einer Flüssigkeit
|
PE20061324A1
(es)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, metodos y usos
|
PT2452694T
(pt)
|
2005-06-30 |
2019-02-21 |
Janssen Biotech Inc |
Anticorpos anti-il-23, composições, métodos e utilizações
|
KR101486397B1
(ko)
|
2005-09-14 |
2015-01-28 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
WO2007070851A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
ES2807928T3
(es)
|
2005-12-29 |
2021-02-24 |
Janssen Biotech Inc |
Anticuerpos anti-IL-23 humanos, composiciones, procedimientos y usos
|
BRPI0707991B8
(pt)
|
2006-02-22 |
2021-05-25 |
Mannkind Corp |
métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
|
CA2642229C
(en)
|
2006-02-24 |
2015-05-12 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
US8037880B2
(en)
*
|
2006-04-07 |
2011-10-18 |
The University Of Western Ontario |
Dry powder inhaler
|
DE102006016904A1
(de)
*
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
DE102006016901A1
(de)
*
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Mundstück für einen Inhalator
|
MX2008013165A
(es)
|
2006-04-12 |
2009-01-29 |
Biodel Inc |
Formulaciones de combinacion de insulina de accion rapida y accion larga.
|
EP3669878A1
(en)
|
2006-08-10 |
2020-06-24 |
Roy C. Levitt |
Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
|
US7905229B2
(en)
|
2006-08-30 |
2011-03-15 |
Kurve Technology, Inc. |
Aerosol generating and delivery device
|
UY30820A1
(es)
|
2006-12-21 |
2008-07-03 |
Centocor Inc |
Uso de agonistas del receptor de glp-1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles lipidicos
|
US20080275030A1
(en)
*
|
2007-01-19 |
2008-11-06 |
Sveinbjorn Gizurarson |
Methods and Compositions for the Delivery of a Therapeutic Agent
|
WO2008156586A2
(en)
|
2007-06-12 |
2008-12-24 |
Alkermes, Inc. |
Inhalation device for powdered substances
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
CA2713413C
(en)
|
2008-02-26 |
2018-11-20 |
Parion Sciences, Inc. |
Poly aromatic sodium channel blockers
|
US8642831B2
(en)
|
2008-02-29 |
2014-02-04 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
MX371521B
(es)
*
|
2008-03-27 |
2020-01-31 |
Mannkind Corp |
Sistema de inhalacion de polvo seco.
|
CN104491962B
(zh)
|
2008-06-13 |
2018-10-23 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
ES2421385T3
(es)
|
2008-06-20 |
2013-09-02 |
Mannkind Corp |
Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
|
WO2010008523A1
(en)
|
2008-07-13 |
2010-01-21 |
Map Pharmaceuticals, Inc. |
Methods and apparatus for delivering aerosolized medication
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
AR073060A1
(es)
|
2008-08-14 |
2010-10-13 |
Arana Therapeutic Ltd |
Anticuerpos anti-il-12/il-23
|
KR101781907B1
(ko)
|
2008-10-31 |
2017-09-26 |
얀센 바이오테크 인코포레이티드 |
파이브로넥틴 타입 ⅲ 도메인 기반 스캐폴드 조성물, 방법 및 용도
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
EA022802B1
(ru)
|
2009-01-23 |
2016-03-31 |
Райджел Фармасьютикалз, Инк. |
Соединения, композиции и способы для лечения заболеваний, опосредованных jak-киназой
|
AU2010213892B2
(en)
|
2009-02-12 |
2014-10-23 |
Janssen Biotech, Inc. |
Fibronectin type III domain based scaffold compositions, methods and uses
|
ES2526875T3
(es)
|
2009-02-23 |
2015-01-16 |
Japan Tobacco, Inc. |
Dispositivo de succión de aroma de tabaco sin calentamiento
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
ES2534947T3
(es)
|
2009-03-25 |
2015-04-30 |
The Board Of Regents Of The University Of Texas System |
Composiciones para la estimulación de resistencia inmunitaria innata de mamíferos a patógenos
|
FR2946537B1
(fr)
|
2009-06-11 |
2012-08-03 |
Valois Sas |
Dispositif d'inhalation de poudre
|
US8734845B2
(en)
|
2009-06-12 |
2014-05-27 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
US9016147B2
(en)
|
2009-11-03 |
2015-04-28 |
Mannkind Corporation |
Apparatus and method for simulating inhalation efforts
|
GB2489383A
(en)
|
2009-12-30 |
2012-09-26 |
Vijayan Thirumalai Anandampillai |
An improved dry powder inhaler
|
AU2011210352A1
(en)
|
2010-01-26 |
2012-08-09 |
Radikal Therapeutics Inc. |
Compositions and methods for prevention and treatment of pulmonary hypertension
|
CA2789629A1
(en)
|
2010-02-10 |
2011-08-18 |
Immunogen, Inc. |
Cd20 antibodies and uses thereof
|
US9315585B2
(en)
|
2010-06-19 |
2016-04-19 |
Memorial Sloan Kettering Cancer Center |
Anti-GD2 antibodies
|
EP2582421A1
(en)
|
2010-06-21 |
2013-04-24 |
MannKind Corporation |
Dry powder drug delivery system and methods
|
SG10201606220QA
(en)
|
2011-04-01 |
2016-09-29 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
WO2012175735A1
(en)
|
2011-06-23 |
2012-12-27 |
Vib Vzw |
A20 inhibitors for the treatment of respiratory viral infections
|
PT2723176T
(pt)
|
2011-06-27 |
2017-07-18 |
Parion Sciences Inc |
Dipéptido química e metabolicamente estável que possui potente atividade bloqueadora do canal de sódio
|
KR20140095483A
(ko)
|
2011-10-24 |
2014-08-01 |
맨카인드 코포레이션 |
통증을 치료하기 위한 방법 및 조성물
|
JP6241624B2
(ja)
|
2012-03-06 |
2017-12-06 |
フェロサン メディカル デバイシーズ エイ/エス |
止血ペーストを収容する加圧容器
|
CA2865504A1
(en)
|
2012-03-23 |
2013-09-26 |
Oxigene, Inc. |
Compositions and methods for inhibition of cathepsins
|
CN104349797B
(zh)
|
2012-06-12 |
2017-10-27 |
弗罗桑医疗设备公司 |
干止血组合物
|
JP6312262B2
(ja)
|
2012-07-12 |
2018-04-18 |
マンカインド コーポレイション |
乾燥粉末薬物送達システム
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
TWI718086B
(zh)
|
2013-01-07 |
2021-02-11 |
英屬維爾京群島商遠東超級實驗室有限公司 |
通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物
|
SG11201507564PA
(en)
|
2013-03-15 |
2015-10-29 |
Mannkind Corp |
Microcrystalline diketopiperazine compositions and methods
|
KR102207859B1
(ko)
|
2013-03-15 |
2021-01-27 |
메모리얼 슬로안 케터링 캔서 센터 |
고 친화도 항-gd2 항체
|
CA2912357C
(en)
|
2013-06-21 |
2019-12-31 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
AU2014290438B2
(en)
|
2013-07-18 |
2019-11-07 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
US11446127B2
(en)
|
2013-08-05 |
2022-09-20 |
Mannkind Corporation |
Insufflation apparatus and methods
|
JP6489485B2
(ja)
|
2013-12-11 |
2019-03-27 |
フェロサン メディカル デバイシーズ エイ/エス |
押し出し増強因子を含んでいる乾燥組成物
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
WO2018140026A1
(en)
|
2017-01-27 |
2018-08-02 |
Memorial Sloan Kettering Cancer Center |
Bispecific her2 and cd3 binding molecules
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
JP6726852B2
(ja)
|
2014-10-13 |
2020-07-22 |
フェッローサン メディカル ディバイス エー/エス |
止血および創傷治癒に使用するための乾燥組成物
|
JP6747650B2
(ja)
|
2014-12-24 |
2020-08-26 |
フェロサン メディカル デバイシーズ エイ/エス |
第1の物質と第2の物質を保持し混合するためのシリンジ
|
ES2929614T3
(es)
|
2015-03-17 |
2022-11-30 |
Memorial Sloan Kettering Cancer Center |
Anticuerpos anti-MUC16 y usos de los mismos
|
EP3316930B1
(en)
|
2015-07-03 |
2019-07-31 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
MX2019000643A
(es)
|
2016-07-15 |
2019-06-13 |
Poseida Therapeutics Inc |
Receptores de antigenos quimericos y metodos de uso.
|
MX2019000641A
(es)
|
2016-07-15 |
2019-06-10 |
Poseida Therapeutics Inc |
Composiciones de mucina1-receptor de antigeno quimerico y metodos para su uso.
|
IL266562B1
(en)
|
2016-11-09 |
2024-07-01 |
Univ Texas |
Pharmaceutical compositions for immune regulation adapted for use in the patient sensitive to allergen-induced asthma
|
WO2018112037A1
(en)
|
2016-12-16 |
2018-06-21 |
Jia Zhou |
Inhibitors of bromodomain-containing protein 4 (brd4)
|
MA47362A
(fr)
|
2017-01-30 |
2019-12-04 |
Janssen Biotech Inc |
Anticorps anti-tnf, compositions et méthodes pour le traitement du rhumatisme psoriasique actif
|
JP2020506947A
(ja)
|
2017-02-07 |
2020-03-05 |
ヤンセン バイオテツク,インコーポレーテツド |
活動性強直性脊椎炎を治療するための抗tnf抗体、組成物、及び方法
|
KR20200116917A
(ko)
|
2017-12-20 |
2020-10-13 |
포세이다 테라퓨틱스, 인크. |
Vcar 조성물 및 사용 방법
|
KR102019593B1
(ko)
*
|
2018-03-06 |
2019-09-06 |
주식회사 케이티앤지 |
에어로졸 흡입기
|
KR102016848B1
(ko)
*
|
2018-03-06 |
2019-08-30 |
주식회사 케이티앤지 |
흡연 물품용 카트리지 및 이의 에어로졸 흡입기
|
KR102019595B1
(ko)
*
|
2018-03-07 |
2019-09-06 |
주식회사 케이티앤지 |
담배 물질 흡입기
|
EP3790613B1
(en)
|
2018-05-08 |
2023-04-26 |
Société Industrielle de Sonceboz S.A. |
Inhaler
|
ES2968412T3
(es)
|
2018-05-09 |
2024-05-09 |
Ferrosan Medical Devices As |
Método para preparar una composición hemostática
|
WO2019215701A1
(en)
|
2018-05-11 |
2019-11-14 |
Janssen Biotech, Inc. |
Methods of treating depression using il-23 antibodies
|
US11389433B2
(en)
|
2018-06-18 |
2022-07-19 |
Board Of Regents, The University Of Texas System |
BRD4 inhibitor treatment of IgE-mediated diseases
|
WO2020092845A1
(en)
|
2018-11-01 |
2020-05-07 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
WO2020121255A1
(en)
|
2018-12-13 |
2020-06-18 |
ResMed Pty Ltd |
Pneumatic block for respiratory pressure therapy device
|
BR112021013903A2
(pt)
|
2019-01-15 |
2021-09-21 |
Janssen Biotech, Inc. |
Composições e métodos de anticorpos anti-tnf para o tratamento da artrite idiopática juvenil
|
KR20210118878A
(ko)
|
2019-01-23 |
2021-10-01 |
얀센 바이오테크 인코포레이티드 |
건선성 관절염의 치료 방법에 사용하기 위한 항-tnf 항체 조성물
|
CA3133381A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
CN113840837A
(zh)
|
2019-03-14 |
2021-12-24 |
詹森生物科技公司 |
用于产生抗tnf抗体组合物的方法
|
JP2022526881A
(ja)
|
2019-03-14 |
2022-05-27 |
ヤンセン バイオテツク,インコーポレーテツド |
抗tnf抗体組成物を産生するための方法
|
BR112021023295A2
(pt)
|
2019-05-23 |
2022-02-08 |
Janssen Biotech Inc |
Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa
|
US20200377518A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
WO2020245676A1
(en)
|
2019-06-03 |
2020-12-10 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis
|
CN114173873A
(zh)
|
2019-06-03 |
2022-03-11 |
詹森生物科技公司 |
用于治疗活动性强直性脊柱炎的抗tnf抗体、组合物和方法
|
BR112022001418A2
(pt)
|
2019-08-08 |
2022-06-07 |
Rigel Pharmaceuticals Inc |
Compostos e método para tratar a síndrome de liberação de citocinas
|
JP2022544276A
(ja)
|
2019-08-14 |
2022-10-17 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
サイトカイン放出症候群をブロック又は改善する方法
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
CA3174777A1
(en)
|
2020-04-14 |
2021-10-21 |
Eric M. Ostertag |
Compositions and methods for use in the treatment of cancer
|
WO2021214587A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating viral infections
|
WO2021214588A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating coronavirus infections
|
KR20230060504A
(ko)
|
2020-07-31 |
2023-05-04 |
파인트리 테라퓨틱스 인코포레이티드 |
바이러스 감염 치료를 위한 뉴로필린 및 안지오텐신 전환 효소 2 융합 펩티드
|
WO2023279115A1
(en)
|
2021-07-02 |
2023-01-05 |
Henry Ford Health System |
Compositions comprising endosidin 2 for reducing sars-cov-2 infection
|
AU2022308201A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
IL309997A
(en)
|
2021-07-09 |
2024-03-01 |
Janssen Biotech Inc |
Production methods for the production of anti-TNF antibody compositions
|
US20230303555A1
(en)
|
2022-03-23 |
2023-09-28 |
Rigel Pharmaceuticals, Inc. |
Pyrimid-2-yl-pyrazole compounds as irak inhibitors
|